TY - JOUR
T1 - EFFECTS OF 25(OH)-VITAMIN D//3 IN HYPOCALCEMIC PATIENTS ON CHRONIC HEMODIALYSIS.
AU - Kronfol, Nouhad O.
AU - Hersh, William R.
AU - Barakat, Mohammad M.
PY - 1987/7/1
Y1 - 1987/7/1
N2 - This study demonstrates the 25(OH)-vitamin D//3, in an initial dose of 100 mu g/day for 2 weeks followed by 100 mu g qod, is effective in treating the hypocalcemia of patients on maintenance hemodialysis. There was one episode of mild hypercalcemia noted, and no significant rise in serum phosphorus in any patient studied. There is evidence in the literature that 25(OH)-vitamin D//3 is converted into both 1,25,(OH)2-vitamin D//3 and 24,25,(OH)2-vitamin D//3 in patients on maintenance hemodialysis, indicating that there are potential advantages of using 25(OH)-vitamin D//3 over 1,25,(OH)2-vitamin D//3 alone in these patients.
AB - This study demonstrates the 25(OH)-vitamin D//3, in an initial dose of 100 mu g/day for 2 weeks followed by 100 mu g qod, is effective in treating the hypocalcemia of patients on maintenance hemodialysis. There was one episode of mild hypercalcemia noted, and no significant rise in serum phosphorus in any patient studied. There is evidence in the literature that 25(OH)-vitamin D//3 is converted into both 1,25,(OH)2-vitamin D//3 and 24,25,(OH)2-vitamin D//3 in patients on maintenance hemodialysis, indicating that there are potential advantages of using 25(OH)-vitamin D//3 over 1,25,(OH)2-vitamin D//3 alone in these patients.
UR - http://www.scopus.com/inward/record.url?scp=0023378454&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0023378454&partnerID=8YFLogxK
M3 - Article
C2 - 3675956
AN - SCOPUS:0023378454
SN - 1058-2916
VL - 33
SP - 289
EP - 292
JO - ASAIO Journal
JF - ASAIO Journal
IS - 3
ER -